These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28876463)

  • 1. Antigenicity reduction contributes mostly to poor detectability of HBsAg by hepatitis B virus (HBV) S-gene mutants isolated from individuals with occult HBV infection.
    Zhang K; Liu Y; Chen R; Li Q; Xu Z; Si L; Cheng Y; Yang Y; Chen J; Xu D; Lin S
    J Med Virol; 2018 Feb; 90(2):263-270. PubMed ID: 28876463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
    Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors.
    Huang CH; Yuan Q; Chen PJ; Zhang YL; Chen CR; Zheng QB; Yeh SH; Yu H; Xue Y; Chen YX; Liu PG; Ge SX; Zhang J; Xia NS
    J Hepatol; 2012 Oct; 57(4):720-9. PubMed ID: 22634131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: Reliable detection of HBV by the Elecsys HBsAg II assay.
    Gencay M; Vermeulen M; Neofytos D; Westergaard G; Pabinger S; Kriegner A; Seffner A; Gohl P; Huebner K; Nauck M; Kaminski WE
    J Clin Virol; 2018 Apr; 101():38-43. PubMed ID: 29414186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are current screening protocols for chronic hepatitis B virus infection adequate?
    Mortensen E; Kamali A; Schirmer PL; Lucero-Obusan C; Winston CA; Oda G; Winters MA; Durfee J; Martinello RA; Davey VJ; Holodniy M
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):159-67. PubMed ID: 27009896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus genotype, HBsAg mutations and co-infection with HCV in occult HBV infection.
    Arababadi MK; Pourfathollah AA; Jafarzadeh A; Hassanshahi G; Salehi M; Ahmadabadi BN; Kennedy D
    Clin Res Hepatol Gastroenterol; 2011 Sep; 35(8-9):554-9. PubMed ID: 21835725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation in the S gene of hepatitis B virus and anti-HBs subtype-nonspecificity contributed to the co-existence of HBsAg and anti-HBs in patients with chronic hepatitis B virus infection.
    Fu X; Chen J; Chen H; Lin J; Xun Z; Li S; Liu C; Zeng Y; Chen T; Yang B; Ou Q
    J Med Virol; 2017 Aug; 89(8):1419-1426. PubMed ID: 28198078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection.
    Svicher V; Cento V; Bernassola M; Neumann-Fraune M; Van Hemert F; Chen M; Salpini R; Liu C; Longo R; Visca M; Romano S; Micheli V; Bertoli A; Gori C; Ceccherini-Silberstein F; Sarrecchia C; Andreoni M; Angelico M; Ursitti A; Spanò A; Zhang JM; Verheyen J; Cappiello G; Perno CF
    Antiviral Res; 2012 Jan; 93(1):86-93. PubMed ID: 22086128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of core protein mutations in the development of occult HBV infection.
    Chen J; Liu B; Tang X; Zheng X; Lu J; Zhang L; Wang W; Candotti D; Fu Y; Allain JP; Li C; Li L; Li T
    J Hepatol; 2021 Jun; 74(6):1303-1314. PubMed ID: 33453326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.
    Chen J; Liu Y; Zhao J; Xu Z; Chen R; Si L; Lu S; Li X; Wang S; Zhang K; Li J; Han J; Xu D
    PLoS One; 2016; 11(5):e0155654. PubMed ID: 27182775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg.
    Sadeghi A; Shirvani-Dastgerdi E; Tacke F; Yagmur E; Poortahmasebi V; Poorebrahim M; Mohraz M; Hajabdolbaghi M; Rasoolinejad M; Abbasian L; Jafari R; Fakhari Z; Norouzi M; Ebrahimian A; Geravand B; Alavian SM; Jazayeri SM
    J Med Virol; 2017 Feb; 89(2):246-256. PubMed ID: 27381922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and molecular characterisation of a diagnosis escape variant associated with occult hepatitis B virus in Brazil.
    Almeida RW; Mello FCDA; Menegoy IV; Santo MPDE; Ginuíno CF; Sousa PSF; Villar LM; Lampe E; Lewis-Ximenez LL
    Mem Inst Oswaldo Cruz; 2017 Jul; 112(7):485-491. PubMed ID: 28591309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence.
    Candotti D; Lin CK; Belkhiri D; Sakuldamrongpanich T; Biswas S; Lin S; Teo D; Ayob Y; Allain JP
    Gut; 2012 Dec; 61(12):1744-53. PubMed ID: 22267593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hepatitis B virus (HBV) preS/S gene mutations in blood donors with occult HBV infection in the Baoji area of North China.
    Liao H; Liu Y; Chen J; Ding W; Li X; Xu Z; Yang Y; Chen R; Si L; Xu X; Guo J; Xu D
    Transfusion; 2017 Mar; 57(3pt2):857-866. PubMed ID: 28236303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.
    Powell EA; Boyce CL; Gededzha MP; Selabe SG; Mphahlele MJ; Blackard JT
    J Gen Virol; 2016 Jul; 97(7):1615-1624. PubMed ID: 27031988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of in vivo hepatitis B virus surface antigen mutations-A comparison of four routine screening assays.
    Gencay M; Seffner A; Pabinger S; Gautier J; Gohl P; Weizenegger M; Neofytos D; Batrla R; Woeste A; Kim HS; Westergaard G; Reinsch C; Brill E; Thuy PTT; Hoang BH; Sonderup M; Spearman CW; Brancaccio G; Fasano M; Gaeta GB; Santantonio T; Kaminski WE
    J Viral Hepat; 2018 Oct; 25(10):1132-1138. PubMed ID: 29660206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-glycosylation mutations within hepatitis B virus surface major hydrophilic region contribute mostly to immune escape.
    Yu DM; Li XH; Mom V; Lu ZH; Liao XW; Han Y; Pichoud C; Gong QM; Zhang DH; Zhang Y; Deny P; Zoulim F; Zhang XX
    J Hepatol; 2014 Mar; 60(3):515-22. PubMed ID: 24239777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA.
    Xiang KH; Michailidis E; Ding H; Peng YQ; Su MZ; Li Y; Liu XE; Dao Thi VL; Wu XF; Schneider WM; Rice CM; Zhuang H; Li T
    J Hepatol; 2017 Feb; 66(2):288-296. PubMed ID: 27650283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia.
    Bubonja-Šonje M; Peruč D; Abram M; Mohar-Vitezić B
    Ann Hepatol; 2024; 29(1):101156. PubMed ID: 37758118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples.
    Thibault V; Servant-Delmas A; Ly TD; Roque-Afonso AM; Laperche S
    J Clin Virol; 2017 Apr; 89():14-21. PubMed ID: 28189936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.